...
首页> 外文期刊>Cellular Physiology and Biochemistry >Sgk-1 is a Positive Regulator of Constitutive Albumin Uptake in Renal Proximal Tubule Cells
【24h】

Sgk-1 is a Positive Regulator of Constitutive Albumin Uptake in Renal Proximal Tubule Cells

机译:Sgk-1是肾脏近端小管细胞中组成型白蛋白摄取的正调节剂。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

biBackground/Aims /i/bReceptor-mediated endocytosis of albumin by the renal proximal tubule requires a number of proteins including megalin/cubilin, sodium/hydrogen exchanger isoform 3 (NHE3) and ClC-5, as well as the PSD-95/Dlg/Zo-1 (PDZ) scaffold sodium/hydrogen exchanger regulatory factor 2 (NHERF2). Despite members from the AGC kinase family, v-Akt Murine Thymoma Viral Oncogene (Akt or Protein Kinase B) and Serum/Glucocorticoid regulated Kinase 1 (Sgk-1) regulating a number of essential proteins in the albumin handling pathway, their role in uptake is largely unknown. biMethods /i/bOpossum kidney (OK) cells were exposed to Texas-Red albumin, in the presence of silencing constructs against Sgk-1, Akt and NHERF2, in addition to the NHE3 inhibitor 5-(iN/i-ethyl-iN/i-isopropyl)-amiloride (EIPA) and NHE3 activator dexamethasone. Target protein was also measured by Western blot analysis in OK cells following exposure to dexamethasone and albumin. biResults /i/bSilencing Sgk-1 or overexpression of a dominant negative mutant (DN-Sgk-1) led to a significant reduction of albumin endocytosis compared to control. Conversely, over-expression of wildtype (WT) or constitutively active (CA) Sgk-1 significantly increased uptake. Previous reports have shown Sgk-1 can activate NHE3 through an interaction mediated by NHERF2. We found that silencing both Sgk-1 and NHERF2 demonstrated no additive effect on uptake, suggesting signaling via similar endpoints. Treatment with dexamethasone increased Sgk-1 protein levels and increased albumin endocytosis in OK cells. Interestingly, silencing Akt also lead to a reduction in albumin endocytosis, however in cells silenced for both Sgk-1 and Akt, the additive change in albumin uptake demonstrated that these proteins may act via separate pathways. biConclusions/i/b We have characterized a Sgk-dependent pathway that regulates albumin uptake in the proximal tubule which also includes NHE3 and NHERF2. These data provide further insights into this essential tubular process.
机译:背景/目的 肾近端小管的受体介导的白蛋白内吞作用需要许多蛋白质,包括巨蛋白/胆碱,钠/氢交换异构体3(NHE3)和ClC- 5,以及PSD-95 / Dlg / Zo-1(PDZ)支架钠/氢交换调节因子2(NHERF2)。尽管有AGC激酶家族的成员,但v-Akt鼠胸腺瘤病毒致癌基因(Akt或蛋白激酶B)和血清/糖皮质激素调节的激酶1(Sgk-1)调节白蛋白处理途径中的许多必需蛋白及其在摄取中的作用。在很大程度上是未知的。 方法 负鼠肾(OK)细胞除了存在NHE3抑制剂外,还存在针对Sgk-1,Akt和NHERF2的沉默构建体,并暴露于德克萨斯红蛋白5-(Ni-乙基-Ni-异丙基)-阿米洛利(EIPA)和NHE3活化剂地塞米松。暴露于地塞米松和白蛋白后,在OK细胞中也通过Western印迹分析测量了目标蛋白。 结果 与对照组相比,Sgk-1沉默或显性负突变体(DN-Sgk-1)的过度表达导致白蛋白内吞作用显着降低。相反,野生型(WT)或组成型活性(CA)Sgk-1的过表达显着增加了摄取。先前的报道显示Sgk-1可以通过NHERF2介导的相互作用激活NHE3。我们发现同时沉默Sgk-1和NHERF2并没有表现出对摄取的累加作用,表明通过相似的终点发出信号。地塞米松治疗可增加OK细胞的Sgk-1蛋白水平并增加白蛋白内吞作用。有趣的是,沉默Akt也会导致白蛋白内吞作用的减少,但是在Sgk-1和Akt都沉默的细胞中,白蛋白摄取的累加变化表明这些蛋白可能通过单独的途径起作用。 结论 我们已经描述了Sgk依赖性途径,该途径调节近端小管中的白蛋白摄取,其中也包括NHE3和NHERF2。这些数据提供了对该基本管状过程的进一步见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号